<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR40">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Geng</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Deng</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Guo</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>W</given-names>
   </name>
  </person-group>
  <article-title>The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists</article-title>
  <source>Protein Cell</source>
  <year>2013</year>
  <volume>4</volume>
  <issue>12</issue>
  <fpage>951</fpage>
  <lpage>961</lpage>
  <pub-id pub-id-type="doi">10.1007/s13238-013-3096-8</pub-id>
  <?supplied-pmid 24318862?>
  <pub-id pub-id-type="pmid">24318862</pub-id>
 </element-citation>
</ref>
